These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26617395)

  • 21. Exercise Enhances the Behavioral Responses to Acute Stress in an Animal Model of PTSD.
    Hoffman JR; Ostfeld I; Kaplan Z; Zohar J; Cohen H
    Med Sci Sports Exerc; 2015 Oct; 47(10):2043-52. PubMed ID: 25699481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intranasal Neuropeptide Y as a Potential Therapeutic for Depressive Behavior in the Rodent Single Prolonged Stress Model in Females.
    Nahvi RJ; Tanelian A; Nwokafor C; Hollander CM; Peacock L; Sabban EL
    Front Behav Neurosci; 2021; 15():705579. PubMed ID: 34566592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The NPY system in stress, anxiety and depression.
    Heilig M
    Neuropeptides; 2004 Aug; 38(4):213-24. PubMed ID: 15337373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Posttraumatic stress disorder (PTSD) as a consequence of the interaction between an individual genetic susceptibility, a traumatogenic event and a social context].
    Auxéméry Y
    Encephale; 2012 Oct; 38(5):373-80. PubMed ID: 23062450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NPY and extreme stress: lessons learned from posttraumatic stress disorder.
    Dutton MA; Lee EW; Zukowska Z
    EXS; 2006; (95):213-22. PubMed ID: 16383009
    [No Abstract]   [Full Text] [Related]  

  • 26. Neuropeptide Y in PTSD, MDD, and chronic stress: A systematic review and meta-analysis.
    Tural U; Iosifescu DV
    J Neurosci Res; 2020 May; 98(5):950-963. PubMed ID: 32048334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blockade of neuropeptide Y(2) receptors and suppression of NPY's anti-epileptic actions in the rat hippocampal slice by BIIE0246.
    El Bahh B; Cao JQ; Beck-Sickinger AG; Colmers WF
    Br J Pharmacol; 2002 Jun; 136(4):502-9. PubMed ID: 12055128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the beta-adrenergic system.
    Pons J; Kitlinska J; Ji H; Lee EW; Zukowska Z
    Can J Physiol Pharmacol; 2003 Feb; 81(2):177-85. PubMed ID: 12710532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Understanding resilience: New approaches for preventing and treating PTSD.
    Horn SR; Charney DS; Feder A
    Exp Neurol; 2016 Oct; 284(Pt B):119-132. PubMed ID: 27417856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropeptide Y increases in vivo hippocampal extracellular glutamate levels through Y1 receptor activation.
    Meurs A; Portelli J; Clinckers R; Balasubramaniam A; Michotte Y; Smolders I
    Neurosci Lett; 2012 Feb; 510(2):143-7. PubMed ID: 22285263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A possible role of neuropeptide Y in depression and stress.
    Morales-Medina JC; Dumont Y; Quirion R
    Brain Res; 2010 Feb; 1314():194-205. PubMed ID: 19782662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DPP4-deficient congenic rats display blunted stress, improved fear extinction and increased central NPY.
    Canneva F; Golub Y; Distler J; Dobner J; Meyer S; von Hörsten S
    Psychoneuroendocrinology; 2015 Mar; 53():195-206. PubMed ID: 25635612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of single-prolonged stress on neurons and their afferent inputs in the amygdala.
    Cui H; Sakamoto H; Higashi S; Kawata M
    Neuroscience; 2008 Mar; 152(3):703-12. PubMed ID: 18308474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The genetic background to PTSD.
    Broekman BF; Olff M; Boer F
    Neurosci Biobehav Rev; 2007; 31(3):348-62. PubMed ID: 17126903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropeptide Y attenuates anxiety- and depression-like effects of cholecystokinin-4 in mice.
    Desai SJ; Borkar CD; Nakhate KT; Subhedar NK; Kokare DM
    Neuroscience; 2014 Sep; 277():818-30. PubMed ID: 25106129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NPY and stress 30 years later: the peripheral view.
    Hirsch D; Zukowska Z
    Cell Mol Neurobiol; 2012 Jul; 32(5):645-59. PubMed ID: 22271177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repeated administration of AC-5216, a ligand for the 18 kDa translocator protein, improves behavioral deficits in a mouse model of post-traumatic stress disorder.
    Qiu ZK; Zhang LM; Zhao N; Chen HX; Zhang YZ; Liu YQ; Mi TY; Zhou WW; Li Y; Yang RF; Xu JP; Li YF
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():40-6. PubMed ID: 23624119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adaptation to extreme stress: post-traumatic stress disorder, neuropeptide Y and metabolic syndrome.
    Rasmusson AM; Schnurr PP; Zukowska Z; Scioli E; Forman DE
    Exp Biol Med (Maywood); 2010 Oct; 235(10):1150-62. PubMed ID: 20881319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early life stress changes concentrations of neuropeptide Y and corticotropin-releasing hormone in adult rat brain. Lithium treatment modifies these changes.
    Husum H; Mathé AA
    Neuropsychopharmacology; 2002 Nov; 27(5):756-64. PubMed ID: 12431850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropeptide Y: a new mediator linking sympathetic nerves, blood vessels and immune system?
    Zukowska Z; Pons J; Lee EW; Li L
    Can J Physiol Pharmacol; 2003 Feb; 81(2):89-94. PubMed ID: 12710520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.